Results 1 to 10 of about 71,029 (345)

Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study [PDF]

Hematology, Transfusion and Cell Therapy
Background: The chronic myeloid leukaemia population, treatment patterns and responses in Portugal are unknown. The aim of this study is to describe these features in a Portuguese reference centre.
Ana Maria Meireles, Rita Calisto, Maria José Bento, Pedro Martinho Gouveia, Susana Bizarro, Manuel Teixeira, Cláudia Moreira, Ana Espírito Santo, Mário Mariz   +8 more
doaj   +2 more sources

Chronic Myeloid Leukaemia in Advanced Phase: An Analytical Evaluation

Journal of Rawalpindi Medical College, 2019
Objective: To evaluate the clinical and morphological features in advanced phase chronic myeloid leukaemia. Methods: This descriptive observational study was conducted at the Pathology Unit of Fauji Foundation Hospital, Rawalpindi from June 2012 till ...
Sehar Khaliq
doaj   +1 more source

A rare case of an elderly male with progression to chronic myeloid leukaemia secondary to chronic lymphocytic leukaemia [PDF]

European Journal of Case Reports in Internal Medicine
Chronic lymphocytic leukaemia (CLL) is a lymphoproliferative disorder characterised by an accumulation of monoclonal B lymphocytes, with an increased risk of secondary cancers.
Sakditad Saowapa, Watsachon Pangkanon, Yaw Adu, Nattanicha Chaisrimaneepan, Diego Olavarria Bernal, Natchaya Polpichai, Pharit Siladech, Jasmine Sekhon   +7 more
doaj   +2 more sources

One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib. [PDF]

Ann Hematol
Pérez-Lamas L, Manzanares M, Hernández Boluda JC, Casado Montero LF, Gómez Casares MT, Ayala R, Xicoy B, Ferrer Marin F, Ortí G, De Paz Arias R, Osorio Prendes S, Perez Lopez R, Mora E, Ruiz Nuño C, Jimenez Velasco A, Boqué C, Sierra Pacho M, Martinez Lopez J, Carreño-Tarragona G, Coiras M, Garcia-Gutierrez V.   +20 more
europepmc   +3 more sources

Insights into Treatment-Free Remission (TFR) outcomes in Chronic Myeloid Leukaemia (CML) - a tertiary centre experience in Malaysia. [PDF]

Blood Res
Liam CCK, Boo YL, Lim LM, Chong SL, Sharif A, Wong YS, Selvaratnam V, Tan SM, Lim SM.   +8 more
europepmc   +3 more sources

Transplantation in chronic myeloid leukaemia [PDF]

The Lancet, 2002
A, Gratwohl, H, Baldomero, A, Urbano-Ispizua   +2 more
openaire   +3 more sources

Divergent gene expression of <i>PTGS1</i> and <i>PTGS2</i> along the disease course of chronic myeloid leukaemia. [PDF]

Front Oncol
Wosniaki DK, Kusma BN, Marin AM, Munhoz EC, Farias JSH, Mendes EB, Aoki MN, Zanette DL.   +7 more
europepmc   +3 more sources

Adult type CML in paediatric age group – a case series from tertiary care hospital

Asian Journal of Medical Sciences, 2021
Chronic myeloid leukaemia is a clonal disorder arising from hematopoietic stem cell, affecting all the lineage of haematopoietic stem cells. The average age of affection in chronic myeloid leukaemia is 60 to 65 years and is extremely rare in childhood ...
Sumaiya Irfan , Sharique Ahmad , Noorin Zaidi, Zarina Farheen   +3 more
doaj   +1 more source

Clinicohaematological Study of Leukaemias at a Tertiary Care Centre, Vindhya Region of India: A Cross-sectional Study [PDF]

National Journal of Laboratory Medicine, 2023
Introduction: Leukaemia is characterised by widespread proliferation of leucocytes and their precursors in the body tissues and is usually associated with qualitative and quantitative changes in circulating white blood cells.
Lekha Ramchandani, Jagannath Jatav, Di ya Bajaj, RK Vineeth Kumar   +3 more
doaj   +1 more source

Chronic myeloid leukaemia presenting as acute small bowel gangrene: A case report

Journal of Acute Disease, 2021
Rationale: Chronic myeloid leukaemia is a myeloproliferative disorder due to clonal hyperproliferation of myeloid cells within the bone marrow. It can present both pro- and anti-thrombotic states.
Jayabal Pandiaraja, Arumugam Shalini
doaj   +1 more source